أفيروزوليد 600 مجم 10 أقراص

Top Selling Products

NOSTA AGE EYE CONTOUR SOFT CREAM 20ML

EGP262.50
Vacation Whitening Cream 60 ml

EGP122.50
BABY JOY NEW BORN (1) 60PCS

EGP280.00
PAMPERS SIZE (2) 60PCS

EGP310.00
FAMILIA TISSUES 500T

EGP25.00
BABY JOY SMALL (2) 60PCS

EGP260.01

Description reviews

Product

Averozolid

Active

Linezolid 600 mg Film coated tablet

Indication

Averozolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Averozolid is not indicated for the treatment of Gram-negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected.

Pneumonia

Nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates) or Streptococcus pneumonia .

Community-acquired pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, or Staphylococcus aureus (methicillin-susceptible isolates only).

Skin and Skin Structure Infections Complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae. linezolid has not been studied in the treatment of decubitus ulcers .Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.

Vancomycin-resistant Enterococcus faecium Infections Vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia.

Dose

Infection *	Dosage and Route of Administration		Recommended Duration of Treatment (consecutive days
	Pediatric Patients† (Birth through 11 Years of Age)	Adults and Adolescents (12 Years and Older)
Nosocomial pneumonia	10 mg/kg oral ‡ every 8 hours	600 mg oral every ‡ 12 hours	10 to 14
Community-acquired pneumonia, including concurrent bacteremia
Complicated skin and skin structure infections
Vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia	10 mg/kg oral‡ every 8 hours	600 mg oral‡ every 12 hours	14 to 28
Uncomplicated skin and skin structure infections	less than 5 yrs: 10 mg/kg oral ‡ every 8 hours 5-11 yrs: 10 mg/kg oral every 12 hours	Adults: 400 mg oral ‡ every 12 hours Adolescents: 600 mg oral ‡ every 12 hours	10 to 14